Detalhe da pesquisa
1.
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Eur Respir J;
61(3)2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36822634
2.
Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).
Eur Respir J;
59(1)2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34172470
3.
COPD patients with chronic bronchitis and higher sputum eosinophil counts show increased type-2 and PDE4 gene expression in sputum.
J Cell Mol Med;
25(2): 905-918, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33295083
4.
Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.
Respir Res;
21(1): 72, 2020 Mar 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32197620
5.
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
Respir Res;
20(1): 180, 2019 Aug 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31399091
6.
Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.
N Engl J Med;
372(21): 1987-95, 2015 May 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25981191
7.
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma.
J Pharmacol Exp Ther;
367(3): 405-413, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30217958
8.
COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition.
Eur Respir J;
56(2)2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32341106
9.
The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D.
Pulm Pharmacol Ther;
32: 101-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25743376
10.
Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab.
Int J Clin Pharmacol Ther;
53(12): 1015-27, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26445140
11.
Omalizumab in patients with allergic (IgE-mediated) asthma and IgE/bodyweight combinations above those in the initially approved dosing table.
Pulm Pharmacol Ther;
28(2): 149-53, 2014 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24657236
12.
Pharmacodynamics of GSK961081, a bi-functional molecule, in patients with COPD.
Pulm Pharmacol Ther;
26(5): 581-7, 2013 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23538170
13.
Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
J Allergy Clin Immunol;
128(2): 315-22, 2011 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21807250
14.
Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET.
ERJ Open Res;
8(1)2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35036420
15.
Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
Respir Med;
180: 106311, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33711782
16.
Measurement of exhaled nitric oxide: comparison of different analysers.
Respirology;
15(8): 1203-8, 2010 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20920124
17.
Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings.
Respir Med;
161: 105809, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32056721
18.
Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON).
Respir Med;
170: 106021, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32843164
19.
A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison.
Respir Med;
102(7): 1033-44, 2008 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18479895
20.
Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study.
Int J Chron Obstruct Pulmon Dis;
13: 3923-3936, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30584293